Targeting IL-17 and TH17 cells in chronic inflammation.
Miossec P, Kolls JK.
Nat Rev Drug Discov. 2012 Oct;11(10):763-76. doi: 10.1038/nrd3794.
IL-17 family: cytokines, receptors and signaling.
Gu C, Wu L, Li X.
Cytokine. 2013 Nov;64(2):477-85. doi: 10.1016/j.cyto.2013.07.022. Epub 2013 Sep 3.
Functional specialization of interleukin-17 family members.
Iwakura Y, Ishigame H, Saijo S, Nakae S.
Immunity. 2011 Feb 25;34(2):149-62. doi: 10.1016/j.immuni.2011.02.012.
A novel homozygous CYP17A1 mutation causes partial 17 alpha-hydroxylase/17,20-lyase deficiency in 46,XX: a case report and literature review.
Chen H, Chen Y, Mao H, Huang H, Lou X.
Blood Press. 2023 Dec;32(1):2195008. doi: 10.1080/08037051.2023.2195008.
Fertility in patients with genetic deficiencies of cytochrome P450c17 (CYP17A1): combined 17-hydroxylase/17,20-lyase deficiency and isolated 17,20-lyase deficiency.
Marsh CA, Auchus RJ.
Fertil Steril. 2014 Feb;101(2):317-22. doi: 10.1016/j.fertnstert.2013.11.011.
Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer.
Meehan EV, Wang K.
Genes (Basel). 2022 Sep 13;13(9):1643. doi: 10.3390/genes13091643.
Retraction Note.
Kowsar Publishing Company.
Iran Red Crescent Med J. 2016 Mar 3;18(3):e43586. doi: 10.5812/ircmj.43586. eCollection 2016 Mar.
Targeting interleukin-17 receptors.
Lee WH, Wu HH, Huang CK.
Oncotarget. 2015 Jul 30;6(21):18244-5. doi: 10.18632/oncotarget.4892.
IL-17 Control of Cutaneous Immune Homeostasis.
Johnston LA, Nagalla RR, Li M, Whitley SK.
J Invest Dermatol. 2024 Jun;144(6):1208-1216. doi: 10.1016/j.jid.2023.11.016. Epub 2024 Apr 26.
IL-17 in Chronic Inflammation: From Discovery to Targeting.
Beringer A, Noack M, Miossec P.
Trends Mol Med. 2016 Mar;22(3):230-241. doi: 10.1016/j.molmed.2016.01.001. Epub 2016 Jan 31.
